<DOC>
	<DOCNO>NCT02125734</DOCNO>
	<brief_summary>The study multicenter , randomize , 2-period , open-label , two arm , cross-over study show superior effect 4 week treatment QVA149 versus tiotropium lung function . Similarly , study aim evaluate patient preference experience treatment regimens patient clinical diagnosis COPD ( GOLD 2013 ) moderate severe airflow limitation symptomatic ( defined CAT score least 10 ) screen despite treated tiotropium</brief_summary>
	<brief_title>Lung Function Patient Preference With QVA149 vs. Tiotropium COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>sign Informed Consent Form stable COPD accord current guideline ( GOLD 2013 ) airflow limitation indicate postbronchodilator FEV1/FVC ratio &lt; 0.70 postbronchodilator FEV1 ≥30 % &lt; 80 % predict normal value Visit 2. current exsmokers smoke history least 10 pack year Patients stable tiotropium ( 18 µg/d ) monotherapy least 8 week Visit 1 Symptomatic patient define patient CAT score ≥ 10 Visit 1 ( Screening ) . Pregnant breast feeding mother Patients condition contraindicate treatment Patients history clinically significant disease Patients clinically significant renal disease Patients myocardial infarction less 6 month prior study entry Patients recent ( less 1 year ) history NYHA Class III/IV leave ventricular failure . Patients narrowangle glaucoma , symptomatic prostatic hyperplasia bladderneck obstruction urinary retention Patients history malignancy organ system Patients COPD exacerbation require treatment antibiotic , and/or systemic steroid ( oral intravenous ) and/or hospitalization 6 week prior Screening Patients respiratory tract infection within 6 week prior Screening Patients history asthma .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>